Aliyacyac, Felimon T.

HRN: 10-64-56  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/10/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/10/2026
06/16/2026
IV
4.5gm
Q6
Dm Foot Right
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: